NK cells in allogeneic bone marrow transplantation.
NK cells, until recently an ignored subset of lymphocytes, have begun to emerge as important cytotoxic effectors. It is now accepted that NK cells together with T cells constitute major actors in graft-versus-leukemia reaction after allogeneic bone marrow transplantation (BMT). Over the last several years the mechanisms regulating the activation of NK cells have been the subject of intense investigations encouraged by the clinical implications that these studies will have. This article provides a general overview of NK-cells biology and regulation pertinent to their function in allogeneic BMT, followed by a review of the in vivo preclinical and clinical evidence for the beneficial effect of NK cells in the adoptive immunotherapy of leukemia.
Voutsadakis
Ioannis A
IA
Division of Hematology and INSERM U487, Institut Gustave-Roussy, Villejuif, France. ivoutsadakis@yahoo.com
D000818:Animals; D016026:Bone Marrow Transplantation; D005786:Gene Expression Regulation; D006801:Humans; D016219:Immunotherapy, Adoptive; D007694:Killer Cells, Natural / Q000502:physiology*; D007938:Leukemia / Q000628:therapy; D051379:Mice; D011971:Receptors, Immunologic / Q000096:biosynthesis; D014184:Transplantation, Homologous
D011971:Receptors, Immunologic